Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease

被引:18
作者
Zhu, Cheng-Gang [1 ]
Zhang, Yan [1 ]
Xu, Rui-Xia [1 ]
Li, Sha [1 ]
Wu, Na-Qiong [1 ]
Guo, Yuan-Lin [1 ]
Sun, Jing [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Div Dyslipidemia, State Key Lab Cardiovasc Dis,FuWai Hosp,Natl Ctr, Beijing 100037, Peoples R China
基金
高等学校博士学科点专项科研基金; 北京市自然科学基金;
关键词
Coronary artery disease; Non-HDL-C; LDL-C; Lipoprotein subfraction; ISCHEMIC-HEART-DISEASE; SMALL DENSE LDL; CARDIOVASCULAR-DISEASE; REMNANT CHOLESTEROL; PCSK9; LEVELS; RISK-FACTOR; ASSOCIATION; MANAGEMENT; RECOMMENDATIONS; DYSLIPIDEMIA;
D O I
10.1016/j.jacl.2015.08.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Conflicting results have been yielded as to whether low-density lipoprotein (LDL) cholesterol (LDL-C) or non-high-density lipoprotein (HDL) cholesterol (non-HDL-C) is a better marker of coronary artery disease (CAD) risk. Recently, plasma LDL and HDL subfractions have been suggested to be more accurately reflecting the lipoproteins' atherogenicity. OBJECTIVE: We sought to compare the relationship between LDL-C or non-HDL-C and lipoprotein subfractions. METHODS: We conducted a cross-sectional study in 351 consecutive stable CAD patients without lipid-lowering therapy. The LDL and HDL separations were performed using the Lipoprint System. The LDL-C levels were measured directly, and the non-HDL-C levels were calculated. RESULTS: The cholesterol concentrations of LDL (large, medium, and small) and HDL (small) particles were increased (all P < .001) by non-HDL-C or LDL-C quartiles, whereas the mean LDL particle size and cholesterol concentrations of HDL (large) were decreased (both P < .001) by non-HDL-C quartiles. In age- and gender-adjusted analysis, the cholesterol in small LDL was much strongly related to non-HDL-C than to LDL-C (r = 0.539 vs 0.397, both P < .001). Meanwhile, the mean LDL particle size was more closely associated with non-HDL-C than LDL-C (r = -0.336 vs r = -0.136, both P < .05). Significantly, the cholesterol in large HDL was negatively correlated with non-HDL-C (r = -0223, P < .001) but not with LDL-C. These correlations were further confirmed by the fully adjusted multivariable linear regression analysis. CONCLUSIONS: Non-HDL-C, in comparison to LDL-C, was more relevant to atherogenic lipoprotein subfractions in patients with stable CAD, supporting that it may be better in assessing cardiovascular risk. (C) 2015 National Lipid Association. All rights reserved.
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [41] Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease
    Vancheri, Chiara
    Morini, Elena
    Prandi, Francesca Romana
    Barilla, Francesco
    Romeo, Francesco
    Novelli, Giuseppe
    Amati, Francesca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [42] Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
    Kuhnast, Susan
    Fiocco, Marta
    van der Hoorn, Jose W. A.
    Princen, Hans M. G.
    Jukema, J. Wouter
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 48 - 63
  • [43] Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease
    Nishizawa, Y
    Shoji, T
    Kakiya, R
    Tsujimoto, Y
    Tabata, T
    Ishimura, E
    Nakatani, T
    Miki, T
    Inaba, M
    KIDNEY INTERNATIONAL, 2003, 63 : S117 - S120
  • [44] Relationship between Coronary Artery Disease and Non-HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS)
    Sasaki, Jun
    Yokoyama, Mitsuhiro
    Matsuzaki, Masunori
    Saito, Yasushi
    Origasa, Hideki
    Ishikawa, Yuichi
    Oikawa, Shinichi
    Itakura, Hiroshige
    Hishida, Hitoshi
    Kita, Toru
    Kitabatake, Akira
    Nakaya, Noriaki
    Sakata, Toshiie
    Shimada, Kazuyuki
    Shirato, Kunio
    Matsuzawa, Yuji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (02) : 194 - 204
  • [45] Cardiovascular disease risk in patients with elevated LDL-C levels: FH vs. non-FH
    Huang, Haomin
    Li, Lamei
    Yang, Anni
    Chen, Tao
    Shi, Ganwei
    Li, Feng
    Wang, Luya
    Cai, Gaojun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [46] Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease
    Dai, Wen
    Long, Junke
    Cheng, Ying
    Chen, Yaqin
    Zhao, Shuiping
    SCIENTIFIC REPORTS, 2018, 8
  • [47] Complement C3 and C-reactive protein levels in patients with stable coronary artery disease
    Ajjan, R
    Grant, PJ
    Futers, TS
    Brown, JM
    Cymbalista, CM
    Boothby, M
    Carter, AM
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (05) : 1048 - 1053
  • [48] Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease
    Arroyo-Espliguero, Ramon
    Avanzas, Pablo
    Quiles, Juan
    Kaski, Juan Carlos
    ATHEROSCLEROSIS, 2009, 204 (01) : 239 - 243
  • [49] Variability of C-Reactive Protein Levels among Patients with Stable Coronary Artery Disease and on Statin Therapy
    Blum, Arnon
    Costello, Rene
    Samsel, Leigh
    Zalos, Gloria
    McCoy, Phil
    Csako, Gyorgy
    Waclawiw, Myron A.
    Cannon, Richard O., III
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (10): : 602 - 605
  • [50] Increased Plasma Non-High-Density Lipoprotein Levels and Poor Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease
    Sivri, Fatih
    Ceyhan, Banu Ozturk
    TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (03)